19 Nov 2013 - ASTRAZENECA

430 News

AstraZeneca Appoints Herzog & de Meuron for Global R&D Centre and Corporate Headquarters
CAMBRIDGE, UK, 19 November 2013 – AstraZeneca has appointed Herzog & de Meuron to design their new centre in Cambridge. The new building will be situated on the Cambridge Biomedical Campus on the southern outskirts of the city and will be home to one of the company’s three global strategic research and development centres and its corporate headquarters. The project takes the increased density and proximity of academia, research and business in Cambridge into account. A central hub of labs will form the focal point for the new centre, which will encourage collaborative working across the organisation and provide easy access for the wider scientific community through an open design and campus environment fostering exchange and collaboration.

Pierre de Meuron:
“Cambridge is a university city with an important historical heritage, not only academic but also architectural and urbanistic. The historical architecture of Cambridge is mostly low-rise with internal courtyards that provide protected environments for people in their study and work. We want some of these qualities to be brought into the new building. Our response to the brief includes intimate spaces for concentration and work, as well as common spaces where everyone meets and comes together. The centre will be a great place for AstraZeneca to work and exchange with the local community of scientists, students and visitors.”